FFA
OCUL icon

Farther Finance Advisors’s Ocular Therapeutix OCUL Stock Holding History

Farther Finance Advisors’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15K Buy
1,529
+277
+22% +$2.51K ﹤0.01% 4162
2026
Q1 		$10.4K Buy
1,252
+661
+112% +$6.3K ﹤0.01% 4082
2025
Q4 		$7.17K Sell
591
-355
-38% -$4.31K ﹤0.01% 4118
2025
Q3 		$11.1K Buy
946
+665
+237% +$7.95K ﹤0.01% 3401
2025
Q2 		$2.61K Sell
281
-689
-71% -$5.39K ﹤0.01% 3607
2025
Q1 		$6.34K Buy
970
+960
+9,600% +$7.38K ﹤0.01% 2946
2024
Q4 		$85 Hold
10
– – ﹤0.01% 3806
2024
Q3 		$87 Hold
10
– – ﹤0.01% 3803
2024
Q2 		$67 Hold
10
– – ﹤0.01% 3655
2024
Q1 		$87 Buy
+10
New +$71 ﹤0.01% 3399

Other funds holding OCUL

DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MMA
Miracle Mile Advisors Los Angeles, California $8.53B AUM 21.43% 1-Year Est. Return
RZH
Relyea Zuckerberg Hanson Stamford, Connecticut $1.2B AUM 28.45% 1-Year Est. Return

Farther Finance Advisors's OCUL Position: Q2 2026 in Review

Farther Finance Advisors increased its Ocular Therapeutix (OCUL) stake by 22% in Q2 2026, buying an estimated $2.51K and bringing the position to 1,529 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #4162.

Farther Finance Advisors first reported a position in OCUL in Q1 2024 and has held it in 10 quarters since. 29 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Farther Finance Advisors held 1,529 shares of Ocular Therapeutix worth $15K as of Q2 2026.
  • Farther Finance Advisors bought 277 Ocular Therapeutix shares in Q2 2026, an estimated $2.51K.
  • Ocular Therapeutix made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4162 holding.
  • Farther Finance Advisors first reported a position in Ocular Therapeutix in Q1 2024 and has held it in 10 quarters since.
  • 29 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.